NCT02108782 2017-07-19Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsAcademic and Community Cancer Research UnitedPhase 2 Withdrawn
NCT00227773 2015-10-08Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsEastern Cooperative Oncology GroupPhase 2 Withdrawn